Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
01/2012
01/19/2012WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof
01/19/2012WO2012007644A1 Novel arylamide derivatives having antiandrogenic properties
01/19/2012US20120015960 Chemical inhibitor of p53-snail binding and pharmaceutical composition for treating cancer disease containing same as its active ingredient
01/19/2012US20120015957 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor
01/19/2012US20120015942 Substituted hydroxamic acids and uses thereof
01/19/2012US20120015928 Amido Compounds And Their Use As Pharmaceuticals
01/19/2012CA2804765A1 Novel arylamide derivatives having antiandrogenic properties
01/18/2012EP2407459A1 Synthetic intermediate in the production of a sulfonamide derivative having PGD2 receptor antagonistic activity
01/18/2012EP2405757A1 Functionalized 4- and 5-vinyl substituted regioisomers of 1,2,3-triazoles via 1,3-dipolar cycloaddition and polymers thereof
01/18/2012EP1902004B1 Onium-alkylsulfonate production method
01/18/2012EP1642894B1 Quaternary ammonium salt, electrolyte, and electrochemical device
01/18/2012EP1546138B1 Raloxifene l-lactate or a hemihydrate thereof, their uses, pharmaceutical compositions and preparation processes
01/18/2012CN1950351B 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
01/18/2012CN102325750A Sulfonamides as trpm8 modulators
01/18/2012CN102321049A Preparation method of N-butyloxycarbonyl pyrrolidine
01/18/2012CN102321048A Saccharin repaglinide amorphous material
01/18/2012CN102321047A Preparation method of cetirizine hydrochloride
01/17/2012US8097752 Antiprotozoal ring-substituted phospholipids
01/17/2012US8097611 Sulfonyl-derivatives as novel or histone deacetylase
01/17/2012CA2537587C Superhigh purity ionic liquid
01/17/2012CA2504269C Piperazinyl and diazapanyl benzamides and benzthioamides
01/12/2012WO2012005229A1 N-hydroxyformamide derivative and pharmaceutical containing same
01/12/2012WO2012003784A1 Pyrazine derivatives,process for manufacture and use thereof
01/12/2012US20120010403 Fluoroboron compound, aminomethylating agent for aromatic ring made of the same, and production method of compound containing aminomethyl aromatic ring using aminomethylating agent
01/12/2012US20120010189 (3-(4-(aminomethyl)phenoxy or phenylthio)azetidin-1-yl)(5-phenyl-1,3,4-oxadiazol-2-yl)methanone compounds
01/12/2012CA2804918A1 N-hydroxyformamide derivative and medicament containing same
01/11/2012EP2404911A1 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
01/11/2012EP2404899A1 Contrast medium for thrombus detection
01/11/2012EP2044043B1 1- ý[- (2, 4-dimethylphenylsulfanyl) -phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
01/11/2012CN102317273A (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
01/11/2012CN102317272A Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine
01/11/2012CN102317257A Process for the preparation of asymmetrical bis(thiosemicarbazones)
01/11/2012CN102311482A Aro-peptide and preparation method as well as medicinal combination and application of aro-peptide
01/11/2012CN102311407A Preparation method for S(+) toloperisone and pharmaceutical use thereof
01/11/2012CN102311406A Method for preparing lasofoxifene intermediate
01/11/2012CN102100695B High-safety medicinal composition of cinepazide, and preparation method and application thereof
01/11/2012CN101209976B Substituted tartaric acid derivatives and use thereof for preparing beta-secretase inhibitor
01/11/2012CN101208320B N-hydroxyamide derivatives and use thereof
01/10/2012US8093379 Macrocyclic serine protease inhibitors
01/10/2012US8093248 Compounds useful for the treatment of conditions associated with weight gain
01/10/2012US8092709 Stabilizers for the stabilization of unsaturated hydrocarbon-based precursor
01/05/2012WO2012003497A1 Napht- 2 -ylacetic acid derivatives to treat aids
01/05/2012US20120004409 Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine
01/05/2012US20120004315 Selective Estrogen Receptor Modulator
01/05/2012US20120004310 Non-peptide bdnf neurotrophin mimetics
01/05/2012US20120004264 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
01/05/2012US20120004227 Cyclohexane derivative having npy y5 receptor antagonism
01/05/2012US20120004225 Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use
01/05/2012US20120004213 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
01/05/2012US20120004207 Therapeutic uses of derivatives of piperidinyl-and piperidinyl-alkyl carbamates
01/05/2012US20120000790 Electrorecovery of metals
01/05/2012CA2802308A1 Napht-2-ylacetic acid derivatives to treat aids
01/04/2012EP1339663B1 Naphthalene derivatives
01/04/2012CN102307872A BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
01/04/2012CN102304104A TRPV1 (transient receptor potential cation channel, subfamily V, member 1) antagonists, and preparation method and medical application thereof
01/04/2012CN102304103A Fenofibrate acid salt, preparation method, pharmaceutical composition and application
01/04/2012CN102304102A Preparation method of 1-methyl piperazine
01/04/2012CN102304101A Process for coproducing piperazine and N-alkyl piperazine
01/04/2012CN102304100A Method for preparing piperazine pyrophosphate
01/04/2012CN102304075A Inhibitors of viral replication
01/04/2012CN101486687B Preparation technique of setastine hydrochloride
01/03/2012US8088921 Method for producing 3-amidinophenylalanine derivatives
01/03/2012US8088917 Ionic liquids
01/03/2012US8088826 Tetrahydro-naphthalene derivatives
01/03/2012US8088823 Tuberculosis treatment using pleuromutilin derivatives
01/03/2012US8088772 Sulfonamides and their use as a medicament
01/03/2012US8088766 Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors
01/03/2012US8088763 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases
01/03/2012US8088762 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
01/03/2012CA2532458C Clear photopolymerizable systems for the preparation of high thickness coatings
01/03/2012CA2528160C Use of 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl) piperazine for neuronal regeneration and functional recovery
01/03/2012CA2486712C Method of treating diabetes
01/03/2012CA2480356C Benzamide derivatives useful as histone deacetylase inhibitors
12/2011
12/29/2011WO2011161201A1 Bisarylsulfonamides useful as kinase inhibitors in the treatment of inflammation and cancer
12/29/2011WO2011160396A1 Method for preparation of ranolazine
12/29/2011US20110319616 Thiazole derivative and process for producing same
12/29/2011US20110319448 Guanidine-containing compounds useful as muscarinic receptor antagonists
12/29/2011US20110319416 Subunit Selective NMDA Receptor Antagonists For The Treatment Of Neurological Conditions
12/29/2011US20110318388 S1P Receptors Modulators and Their Use Thereof
12/28/2011EP2399912A2 An exo-selective synthesis of himbacine analogs
12/28/2011EP2398785A1 Purification of 1-ý2-(2,4-dimethylphenylsulfanyl)phenyl¨piperazine
12/28/2011EP1158985B1 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
12/28/2011CN102295623A 一种由乙烯酮制备n-乙酰吗啉的方法 One kind of ketene prepared n- acetyl morpholine Method
12/28/2011CN102295622A 一种雷诺嗪的制备方法 One kind of ranolazine preparation
12/28/2011CN102295621A 吗啉改性对叔丁基酚醛树脂及其制备方法 Morpholino-modified phenolic resin and p-tert-butyl-preparation
12/28/2011CN102295611A 一种神经激肽1受体拮抗剂类药物的合成方法 Synthesis of a neurokinin 1 receptor antagonist drugs
12/27/2011US8084645 4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors
12/27/2011US8084623 heterocyclic ketones such as (3-Benzyl-pyrrolidin-3-yl)-(1H-indol-5-yl)-methanone, used as antidepressants or anxiolytic agents
12/27/2011US8084615 Antibacterial agents
12/27/2011US8084607 Apoptosis promoters
12/27/2011US8084606 Process for preparation of substantially optically pure levorotatory and dextrorotatory enantiomers of cetirizine using novel intermediates
12/27/2011US8084503 Indene derivatives as pharmaceutical agents
12/22/2011WO2011157710A1 Process for preparing a cyclic tertiary methylamine
12/22/2011WO2011119345A3 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
12/22/2011US20110313158 Two Component Recyclable Heterogeneous Catalyst, Process for Preparation Thereof and its Use for Preparation of Amines
12/22/2011US20110312987 Salt of naphthyridine carboxylic acid derivative
12/22/2011US20110312931 Glycine transporter-1 inhibitors, methods of making them, and uses thereof
12/22/2011US20110311884 Pentacyclic anion salt and use thereof as an electrolyte
12/22/2011US20110311482 Hepatitis C Virus Inhibitors
12/21/2011EP2396308A1 New production method
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 341